Predicting how function, thinking, and life quality change in older adults with advanced lung cancer
Official title: Predicting trajectories of function, cognition, and quality of life among older adults with advanced lung cancer
Funded at Kaiser Foundation Research Institute · NIH-11401395 · Data updated 2026-11-12
This project aims to better predict how older adults with advanced non-small cell lung cancer will fare in daily living, thinking, and overall well‑being during treatment.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project start | August 25, 2025 |
| Project end | July 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $656,459 |
| NIH project number | 5R37CA306402-02 |
| Project ID | NIH-11401395 on NIH RePORTER |
Who could benefit from this research
✓Could help
Older adults (typically 65+) with advanced non-small cell lung cancer considering or receiving treatment, especially those concerned about impact on daily living and cognition.
✕Less likely to help
Patients unlikely to benefit are those not considering treatment choices or not interested in survivorship outcomes like function or cognition.
What this research studies
Older adults with non-small cell lung cancer often experience more treatment-related toxicity, which can affect their ability to function, think clearly, and enjoy life. The project seeks to develop patient-centered predictions of how these survivorship outcomes unfold over time, helping patients and doctors choose treatments that balance effectiveness with quality of life. Researchers will use data from diverse older patients to identify factors that influence trajectories of function, cognition, and quality of life during therapy, including immunotherapy with or without chemotherapy. The goal is to provide personalized information to support shared decision-making for treatment options in advanced cancer. This work could lead to better guidance on who might tolerate specific therapies and when supportive care or alternative strategies are appropriate.
Why it matters
Potential benefit: Patients could receive more personalized information to choose treatments that preserve function and quality of life.
How similar studies have gone: Previous work has shown promise in identifying factors that influence treatment tolerance and quality of life, though this exact trajectory prediction approach is developing.
Where this research is happening
-
Kaiser Foundation Research Institute
Oakland, United States Active
Researchers
- Principal investigator: Wong, Melisa L — Kaiser Foundation Research Institute
- Study coordinator: Wong, Melisa L
Related research
Other NIH-funded projects on the same topics.
-
Spatial control of immunogenic cancer killing for locally advanced lung cancer
A new approach uses radiation-triggered nanoparticles to deliver cancer-killing drugs directly to lung tumors while sparing healthy tissue.
-
Pathways: a hopeful program to help advanced lung cancer patients pursue personal goals and improve well-being
A brief, hope-based program helps adults with advanced lung cancer stay connected to goals in family, work, and daily life to support mental health and quality of life during treatment.
-
Comprehensive genetic testing for advanced lung cancer
This project looks at how using wide genetic testing that checks hundreds of cancer genes might help people with advanced non-small cell lung cancer and influence care decisions and costs.
-
Inhalable treatment for advanced lung cancer using engineered Influenza A virus
This study is testing a new inhalable treatment for lung cancer that has spread, using a specially designed virus to help your body fight the cancer while keeping healthy cells safe, and it’s aimed at improving survival for patients like you.
-
Brief behavioral support to help breathlessness in advanced lung cancer
A multi-site study tests a short behavioral program delivered by nurses to help adults with advanced lung cancer feel less breathless and more able to do daily activities.
-
Pathways: Supporting Mental Health and Quality of Life for People with Advanced Lung Cancer
This project offers a new program called "Pathways" to help people with advanced lung cancer achieve their personal goals and improve their well-being during treatment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.